The Bacterial Flora in Inflammatory Bowel Disease: Current Insights in Pathogenesis and the Influence of Antibiotics and Probiotics
The DOI matches its Crossref record; 153 of the 155 references it cites were found in a registry or an index, and 2 are not checked yet.
Abstract
The pathogenesis of inflammatory bowel disease (IBD) remains unknown, although in recent years more data have become available. The contribution of genetic and environmental factors is evident, and the luminal bacterial flora plays a major role in the initiation and perpetuation of chronic IBD. Animal models of IBD have shown that colitis does not occur in a germ-free environment. In human IBD, inflammation is present in parts of the gut containing the highest bacterial concentrations. Moreover, the terminal ileum, caecum and rectum are areas of relative stasis, providing prolonged mucosal contact with luminal contents. Enhanced mucosal permeability may play a pivotal role in maintaining a chronic inflammatory state, due to a genetic predisposition or as a result of direct contact with bacteria or their products. A detective epithelial barrier may cause a loss of tolerance to the normal enteric flora. Furthermore, an increased mucosal absorption of viable bacteria and bacterial products is found in IBD. Serum and secreted antibodies are increased and mucosal T-lymphocytes that recognize luminal bacteria are present. However, there is evidence that the immune system reacts over aggressively towards the normal luminal flora rather than the flora being altered in IBD. Several approaches have been used in attempts to discover a specific microbial agent in the cause of IBD. These include demonstration of the presence of organisms or specific antigens in affected tissues, culture of microbes firm the affected tissues, demonstration of serological responses to several agents, and localization and detection of individual pathogen-specific nucleic acid sequences in affected tissue by in situ hybridization and polymerase chain reaction. So far, no specific micro-organism has been directly associated with the pathogenesis of IBD. Analysis of the luminal enteric flora, however, has revealed differences in the composition of this flora compared to healthy controls. In Crohn disease, concentrations of Bacteroides, Eubacteria and Peptostreptococcus are increased, whereas Bifidobacteria numbers are significantly reduced. Furthermore, in ulcerative colitis, concentrations of facultative anaerobic bacteria are increased. The arrival of new molecular techniques qualifying and quantifying the complex intestinal flora has induced a revival of interest in this microflora. Therapeutic approaches geared towards changing the environment at the mucosal border have been attempted by the use of elemental diets, total parenteral nutrition, surgical diversion of the faecal stream and antibiotics. Over the past few years, the use of probiotics in IBD and other intestinal disorders has gained attention. Strengthened by promising experimental data and commercial interests, research in this field is rapidly expanding. Manipulation of the colonic bacteria with antibiotic drugs and probiotic agents may prove to be more effective and better tolerated than immunosuppressants in the future.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Imbalanced microbiota may be one such factor, as deviations in microbiota have been seen in IBS 23-25 and as studies on inflammatory bowel disease imply that the microbiota is able to trigger mucosal inflammation. 26”
From Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota (2008) · cites this paper as [26]
In the citing paper
“Microbiota composition is tightly interlinked with inflammation. 26”
From Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota (2008) · cites this paper as [26]
Citations
Cites
Heid, C. A., Stevens, J., Livak, K. J., & Williams, P. M. (1996) · Genome Research · doi:10.1101/gr.6.10.986 · Cited by 6,174
UNIDENTIFIED CURVED BACILLI ON GASTRIC EPITHELIUM IN ACTIVE CHRONIC GASTRITIS
ROBINWARREN, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92719-8 · Cited by 3,597
MICROBIAL ECOLOGY OF THE GASTROINTESTINAL TRACT
Savage, D. C. (1977) · Annual Review of Microbiology · doi:10.1146/annurev.mi.31.100177.000543 · Cited by 2,436
Inflammatory bowel disease: Etiology and pathogenesis
Fiocchi, C. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70381-6 · Cited by 2,059
Muyzer, G., & Smalla, K. (1998) · Antonie van Leeuwenhoek · doi:10.1023/a:1000669317571 · Cited by 2,044
Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin
Gibson, G. R., Beatty, E. R., Wang, X., & Cummings, J. H. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90192-2 · Cited by 1,528
16S rRNA sequences reveal numerous uncultured microorganisms in a natural community
Ward, D. M., Weller, R., & Bateson, M. M. (1990) · Nature · doi:10.1038/345063a0 · Cited by 1,383
Identification of the Uncultured Bacillus of Whipple’s Disease
Relman, D. A., Schmidt, T. M., MacDermott, R. P., & Falkow, S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207303270501 · Cited by 1,157
Rembacken, B., Snelling, A., Hawkey, P., Chalmers, D., & Axon, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06343-0 · Cited by 1,101
Karmali, M., Petric, M., Steele, B., & Lim, C. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91795-6 · Cited by 1,035
Colonization resistance of the digestive tract in conventional and antibiotic-treated mice
Van der Waaij, D., Berghuis-de Vries, J. M., & Lekkerkerk-van der Wees, J. E. C. (1971) · Journal of Hygiene · doi:10.1017/s0022172400021653 · Cited by 901
Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease
Darfeuille-Michaud, A., Neut, C., Barnich, N., Lederman, E., Di Martino, P., Desreumaux, P., Gambiez, L., Joly, B., Cortot, A., & Colombel, J.-F. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70019-8 · Cited by 877
D'Haens, G. R., Geboes, K., Peeters, M., Baert, F., Penninckx, F., & Rutgeerts, P. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70476-7 · Cited by 868
Intestinal flora in health and disease
Simon, G. L., & Gorbach, S. L. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90606-1 · Cited by 822
KRUIS, W., SCHÜTZ, E., FRIC, P., FIXA, B., JUDMAIER, G., & STOLTE, M. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.00225.x · Cited by 775
HOLLANDER, D., VADHEIM, C. M., BRETTHOLZ, E., PETERSEN, G. M., DELAHUNTY, T., & ROTTER, J. I. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-6-883 · Cited by 760
Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum
Rutgeerts, P., Peeters, M., Hiele, M., Vantrappen, G., Pennincx, F., Aerts, R., Kerremans, R., & Goboes, K. (1991) · The Lancet · doi:10.1016/0140-6736(91)90663-a · Cited by 759
Rutgeerts, P., Hiele, M., Geboes, K., Peeters, M., Penninckx, F., Aerts, R., & Kerremans, R. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90121-3 · Cited by 743 · cited 1×
“Furthermore, in a single report, metronidazole reduced endoscopic and clinical recurrence of CD after ileal resection (142).”
BackgroundINFECTIONS OF THE GASTRO-INTESTINAL TRACT
(1980) · An Introduction to Microbiology for Nurses · doi:10.1016/b978-0-433-30301-5.50017-5 · Cited by 617
Adsorption of Microorganisms to Surfaces. 1980
Bitton, G., & Marshall, K. C. (1980) · Soil Science · doi:10.1097/00010694-198011000-00012 · Cited by 608
Venturi, Gionchetti, Rizzello, Johansson, Zucconi, Brigidi, Matteuzzi, & Campieri (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00560.x · Cited by 567
Studies on the Intestinal Flora
Drasar, B. S., Shiner, M., & McLeod, G. M. (1969) · Gastroenterology · doi:10.1016/s0016-5085(69)80067-3 · Cited by 562
Double blind, placebo controlled trial of metronidazole in Crohn's disease.
Sutherland, L., Singleton, J., Sessions, J., Hanauer, S., Krawitt, E., Rankin, G., Summers, R., Mekhjian, H., Greenberger, N., & Kelly, M. (1991) · Gut · doi:10.1136/gut.32.9.1071 · Cited by 528
Ecological control of the gastrointestinal tract. The role of probiotic flora
BENGMARK, S. (1998) · Gut · doi:10.1136/gut.42.1.2 · Cited by 509
Metronidazole Therapy for Perineal Crohn's Disease: A Follow-Up Study
Brandt, L. J., Bernstein, L. H., Boley, S. J., & Frank, M. S. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80332-6 · Cited by 468
Pouchitis following heal pouch-anal anastomosis: Definition, pathogenesis, and treatment
Sandborn, W. J. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90832-x · Cited by 415
Mackowiak, P. A. (1982) · New England Journal of Medicine · doi:10.1056/nejm198207083070203 · Cited by 389
Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease
Ruemmele, F. M., Targan, S. R., Levy, G., Dubinsky, M., Braun, J., & Seidman, E. G. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70252-5 · Cited by 379
Childhood Factors in Ulcerative Colitis and Crohn's Disease: An International Cooperative Study
Gilat, T., Hacohen, D., Lilos, P., & Langman, M. J. S. (1987) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528708991950 · Cited by 369
Ursing, B., Alm, T., Bárány, F., Bergelin, I., Ganrot-Norlin, K., Hoevels, J., Huitfeldt, B., Jarnerot, G., Krause, U., Krook, A., et al. (1982) · Gastroenterology · doi:10.1016/s0016-5085(82)80189-3 · Cited by 352
Dianda, L., Hanby, A., Wright, N. A., Sebesteny, A., Hayday, A., & Owen, M. J. (1997) · Europe PMC (PubMed Central) · Cited by 336
Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease.
Main, J., McKenzie, H., Yeaman, G. R., Kerr, M. A., Robson, D., Pennington, C. R., & Parratt, D. (1988) · BMJ · doi:10.1136/bmj.297.6656.1105 · Cited by 331
Studies of Intestinal Microflora
Gorbach, S. L., Plaut, A. G., Nahas, L., Weinstein, L., Spanknebel, G., & Levitan, R. (1967) · Gastroenterology · doi:10.1016/s0016-5085(19)34122-8 · Cited by 329
Malin, M., Suomalainen, H., Saxelin, M., & Isolauri, E. (1996) · Annals of Nutrition and Metabolism · doi:10.1159/000177907 · Cited by 316
Schultsz, C., van den Berg, F. M., ten Kate, F. W., Tytgat, G. N. J., & Dankert, J. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70393-8 · Cited by 312
Prantera, C., Zannoni, F., Scribano, M. L., Berto, E., Andreoli, A., Kohn, A., & Luzi, C. (1996) · PubMed · Cited by 309
Gorbach, S. L. (1971) · Gastroenterology · doi:10.1016/s0016-5085(71)80039-2 · Cited by 306
Treatment of ulcerative colitis by implantation of normal colonic flora
Bennet, J., & Brinkman, M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91183-5 · Cited by 304
Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis
Madden, M. V., McIntyre, A. S., & Nicholls, R. J. (1994) · Digestive Diseases and Sciences · doi:10.1007/bf02093783 · Cited by 299
Controlled trial of bowel rest and nutritional support in the management of Crohn's disease
Greenberg, G. R., Fleming, C. R., Jeejeebhoy, K. N., Rosenberg, I. H., Sales, D., & Tremaine, W. J. (1988) · Gut · doi:10.1136/gut.29.10.1309 · Cited by 296 · cited 1×
“Total parenteral nutrition (TPN) or elemental diets reproducibly diminish symptoms and objective evidence of in ammation in CD, particularly in the case of small-bowel involvement, but not in UC (148).”
BackgroundLiu, Y., Van Kruiningen, H. J., West, A. B., Cartun, R. W., Cortot, A., & Colombel, J.-F. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90687-8 · Cited by 291
Studies of Intestinal Microflora
Gorbach, S. L., Nahas, L., Lerner, P. I., & Weinstein, L. (1967) · Gastroenterology · doi:10.1016/s0016-5085(19)34121-6 · Cited by 284
Chapman, R. W., Selby, W. S., & Jewell, D. P. (1986) · Gut · doi:10.1136/gut.27.10.1210 · Cited by 284
Pouchitis: result of microbial imbalance?
Ruseler-van Embden, J. G., Schouten, W. R., & van Lieshout, L. M. (1994) · Gut · doi:10.1136/gut.35.5.658 · Cited by 255
Colombel, J. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00816-8 · Cited by 254
Some current concepts in intestinal bacteriology
Moore, W., Cato, E., & Holdeman, L. (1978) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/31.10.s33 · Cited by 253
Evidence of persistent measles virus infection in Crohn's disease
Wakefield, A. J., Pittilo, R. M., Sim, R., Cosby, S. L., Stephenson, J. R., Dhillon, A. P., & Pounder, R. E. (1993) · Journal of Medical Virology · doi:10.1002/jmv.1890390415 · Cited by 248
Antibiotic combination therapy in patients with chronic, treatment‐resistant pouchitis
Gionchetti, P., Rizzello, F., Venturi, A., Ugolini, F., Rossi, M., Brigidi, P., Johansson, R., Ferrieri, A., Poggioli, G., & Campieri, M. (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00553.x · Cited by 242
The effect of probiotic bacteria on the adhesion of pathogens to human intestinal mucus
Tuomola, E. (1999) · FEMS Immunology and Medical Microbiology · doi:10.1016/s0928-8244(99)00131-5 · Cited by 230
Digestion, excretion, and energy value of fructooligosaccharides in healthy humans
Molis, C., Flourié, B., Ouarne, F., Gailing, M., Lartigue, S., Guibert, A., Bornet, F., & Galmiche, J. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/64.3.324 · Cited by 230
Metronidazole therapy for Crohn's disease and associated fistulae.
Jakobovits, J., & Schuster, M. M. (1984) · PubMed · Cited by 227
Thayer, W. R., Coutu, J. A., Chiodini, R. J., Van Kruiningen, H. J., & Merkal, R. S. (1984) · Digestive Diseases and Sciences · doi:10.1007/bf01317079 · Cited by 226
Fecal β-D-Galactosidase Production and Bifidobacteria Are Decreased in Crohn's Disease
Favier, C., Neut, C., Mizon, C., Cortot, A., Colombel, J. F., & Mizon, J. (1997) · Digestive Diseases and Sciences · doi:10.1023/a:1018876400528 · Cited by 220
Campieri, M., & Gionchetti, P. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70029-6 · Cited by 218
The Membranous Epithelial (M) Cell and the Mucosal Immune System
Wolf, J. L., & Bye, W. A. (1984) · Annual Review of Medicine · doi:10.1146/annurev.me.35.020184.000523 · Cited by 214
Development of anaerobic fecal flora in healthy newborn infants
Long, S. S., & Swenson, R. M. (1977) · The Journal of Pediatrics · doi:10.1016/s0022-3476(77)80836-6 · Cited by 204
Krogfelt, K. A. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.4.721 · Cited by 197
Ambrose, N. S., Johnson, M., Burdon, D. W., & Keighley, M. R. B. (1984) · Journal of British Surgery · doi:10.1002/bjs.1800710821 · Cited by 195
Fluorescently labelled, rRNA‐targeted oligonucleotide probes in the study of microbial ecology
AMANN, R. I. (1995) · Molecular Ecology · doi:10.1111/j.1365-294x.1995.tb00255.x · Cited by 189
Rigaud, D., Cosnes, J., Le Quintrec, Y., René, E., Gendre, J. P., & Mignon, M. (1991) · Gut · doi:10.1136/gut.32.12.1492 · Cited by 187
Dickinson, R. J., O'Connor, H. J., Pinder, I., Hamilton, I., Johnston, D., & Axon, A. T. (1985) · Gut · doi:10.1136/gut.26.12.1380 · Cited by 184
Anti-Saccharomyces cerevisiae mannan antibodies in familial crohn's disease
Sendid, B. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00296-2 · Cited by 179
Childhood infections and the risk of inflammatory bowel disease
Wurzelmann, J. I., Lyles, C. M., & Sandler, R. S. (1994) · Digestive Diseases and Sciences · doi:10.1007/bf02088342 · Cited by 175
Mantzaris, G. J., Hatzis, A., Kontogiannis, P., & Triadaphyllou, G. (1994) · PubMed · Cited by 171
The efficacy of tobramycin in the treatment of ulcerative colitis
BURKE, D. A., AXON, A. T. R., CLAYDEN, S. A., DIXON, M. F., JOHNSTON, D., & LACEY, R. W. (1990) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1990.tb00456.x · Cited by 166
Probiotics and inflammatory bowel diseases
SCHULTZ, M. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00812-6 · Cited by 166
Perinatal measles infection and subsequent Crohn's disease
Ekbom, A., Adami, H. O., Wakefield, A., & Zack, M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91898-8 · Cited by 162
Russel, M., Dorant, E., Brummer, R., van de Kruijs, M., Muris, J., Bergers, J., Goedhard, J., & Stockbrugger, R. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9247453 · Cited by 161
Escherichia coli antibodies in patients with inflammatory bowel disease.
Tabaqchali, S., O’Donoghue, D., & Bettelheim, K. A. (1978) · Gut · doi:10.1136/gut.19.2.108 · Cited by 161
The normal colonic bacterial flora.
Hill, M. J., & Drašar, B. S. (1975) · Gut · doi:10.1136/gut.16.4.318 · Cited by 158
Gut Flora in Normal and Disordered States
Salminen, S., Isolauri, E., & Onnela, T. (1995) · Chemotherapy · doi:10.1159/000239391 · Cited by 155
Cell-mediated immunity to intestinal infection
MacDonald, T. T., & Carter, P. B. (1980) · Infection and Immunity · doi:10.1128/iai.28.2.516-523.1980 · Cited by 154
Brandwein, S. L., McCabe, R. P., Cong, Y., Waites, K. B., Ridwan, B. U., Dean, P. A., Ohkusa, T., Birkenmeier, E. H., Sundberg, J. P., & Elson, C. O. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.44 · Cited by 154
Gionchetti, P., Rizzello, F., Ferrieri, A., Venturi, A., Brignola, C., Ferretti, M., Peruzzo, S., Miglioli, M., & Campieri, M. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026648812439 · Cited by 150
(1979) · Food and Cosmetics Toxicology · doi:10.1016/0015-6264(79)90299-2 · Cited by 150
Impairment of Bacterial Flora in Human Ulcerative Colitis and Experimental Colitis in the Rat
Fabia, R., Ar’Rajab, A., Johansson, M.-L., Andersson, R., Willén, R., Jeppsson, B., Molin, G., & Bengmark, S. (1993) · Digestion · doi:10.1159/000201045 · Cited by 147
Sutton, C. L., Yang, H., Li, Z., Rotter, J. I., Targan, S. R., & Braun, J. (2000) · Gut · doi:10.1136/gut.46.1.58 · Cited by 146
Bouma, G., Xia, B., Crusius, J. B. A., Bioque, G., Κoutroubakis, I. E., Blomberg, B. M. E. V., Meuwissen, S. G. M., & Peña, A. S. (1996) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1996.tb08292.x · Cited by 145
Self-citationDrasar, B. S., & Shiner, M. (1969) · Gut · doi:10.1136/gut.10.10.812 · Cited by 137
Crohn's disease after in-utero measles virus exposure
Ekbom, A., Daszak, P., Kraaz, W., & Wakefield, A. J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04429-7 · Cited by 134
Moore, W. E., & Holdeman, L. V. (1974) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/27.12.1450 · Cited by 132
THE ROLE OF THE MUCOSAL IMMUNE SYSTEM IN INFLAMMATORY BOWEL DISEASE
Schreiber, S., Raedler, A., Stenson, W. F., & MacDermott, R. P. (1992) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00040-6 · Cited by 129
Lewis, S. J., & Freedman, A. R. (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00386.x · Cited by 121
Mucosa-associated bacterial flora of the human colon
Poxton, I. R., Brown, R., Sawyerr, A., & Ferguson, A. (1997) · Journal of Medical Microbiology · doi:10.1099/00222615-46-1-85 · Cited by 116
Blaser, M. J., Miller, R. A., Lacher, J., & Singleton, J. W. (1984) · Gastroenterology · doi:10.1016/0016-5085(84)90084-2 · Cited by 115
STUDIES ON THE STABILITY OF THE NORMAL HUMAN FECAL FLORA
Zubrzycki, L., & Spaulding, E. H. (1962) · Journal of Bacteriology · doi:10.1128/jb.83.5.968-974.1962 · Cited by 113
Rhodes, J. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91563-9 · Cited by 110
A prospective study of viral and mycoplasma infections in chronic inflammatory bowel disease
Kangro, H. O., Chong, S., Hardiman, A., Heath, R. B., & Walker-Smith, J. A. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90272-3 · Cited by 108
A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis.
Mantzaris, G. J., Archavlis, E., Christoforidis, P., Kourtessas, D., Amberiadis, P., Florakis, N., Petraki, K., Spiliadi, C., & Triantafyllou, G. (1997) · PubMed · Cited by 106
Giaffer, M. H., Clark, A., & Holdsworth, C. D. (1992) · Gut · doi:10.1136/gut.33.8.1071 · Cited by 106
The Role of the Fecal Stream in Crohnʼs Disease: An Historical and Analytic Review
Janowitz, H. D., Croen, E. C., & Sachar, D. B. (1998) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199802000-00006 · Cited by 103
Environmental risk factors in inflammatory bowel disease.
Κoutroubakis, I. E., Manousos, O. N., Meuwissen, S. G. M., & Peña, A. S. (1996) · PubMed · Cited by 102
Self-citationParamyxovirus infections in childhood and subsequent inflammatory bowel disease
Montgomery, S., Morris, D. L., Pounder, R. E., & Wakefield, A. J. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70062-4 · Cited by 102
Van de Merwe, J. P., Schröder, A. M., Wensinck, F., & Hazenberg, M. P. (1988) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528809090179 · Cited by 101
Serum antibodies to cow's milk proteins in ulcerative colitis and Crohn's disease
Knoflach, P., Park, B. H., Cunningham, R., Weiser, M. M., & Albini, B. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90145-4 · Cited by 100
Colonic glycoproteins in monozygotic twins with inflammatory bowel disease
Tysk, C., Riedesel, H., Lindberg, E., Panzini, B., Podolsky, D. K., & Järnerot, G. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90211-3 · Cited by 98
THE FAECAL FLORA IN ULCERATIVE COLITIS
van der Wiel-Korstanje, J. A. A., & Winkler, K. C. (1975) · Journal of Medical Microbiology · doi:10.1099/00222615-8-4-491 · Cited by 97
Is There a Role for Antibiotics as Primary Therapy in Crohnʼs Ileitis?
Peppercorn, M. A. (1993) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199310000-00013 · Cited by 94
Anaerobic gram-negative faecal flora in patients with Crohn's Disease and healthy subjects
Embden, J. G. H. R.-V., & Both-Patoir, H. C. (1983) · Antonie van Leeuwenhoek · doi:10.1007/bf00393670 · Cited by 90
Controlled trial of antituberculous chemotherapy in Crohn’s disease: a five year follow up study
Thomas, G. A. O., Swift, G. L., Green, J. T., Newcombe, R. G., Braniff-Mathews, C., Rhodes, J., Wilkinson, S., Strohmeyer, G. W., & Kreuzpainter, G. (1998) · Gut · doi:10.1136/gut.42.4.497 · Cited by 89
Casellas, F., Borruel, N., Papo, M., Guarner, F., Antolín, M., Videla, S., & Malagelada, J.-R. (1998) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199802000-00001 · Cited by 88
Haga, Y., Funakoshi, O., Kuroe, K., Kanazawa, K., Nakajima, H., Saito, H., Murata, Y., Munakata, A., & Yoshida, Y. (1996) · Gut · doi:10.1136/gut.38.2.211 · Cited by 88
The faecal flora of patients with Crohn's disease
Wensinck, F., Custers-van Lieshout, L. M. C., Poppelaars-Kustermans, P. A. J., & Schröder, A. M. (1981) · Journal of Hygiene · doi:10.1017/s0022172400069187 · Cited by 85
Microflora of the human small intestine
Thadepalli, H., Lou, S. M. A., Bach, V. T., Matsui, T. K., & Mandal, A. K. (1979) · The American Journal of Surgery · doi:10.1016/0002-9610(79)90309-x · Cited by 82
The Effect of Dietary Yeast on the Activity of Stable Chronic Crohn's Disease
Barclay, G. R., McKenzie, H., Pennington, J., Parratt, D., & Pennington, C. R. (1992) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529208999948 · Cited by 80
The rectal mucosa-associated microflora in patients with ulcerative colitis
HARTLEY, M. G., HUDSON, M. J., SWARBRICK, E. T., HILL, M. J., GENT, A. E., HELLIER, M. D., & GRACE, R. H. (1992) · Journal of Medical Microbiology · doi:10.1099/00222615-36-2-96 · Cited by 80
Circulating Antibodies to Bovine Albumin in Ulcerative Colitis and Crohn's Disease
Falchuk, K. R., & Isselbacher, K. J. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80394-0 · Cited by 76
Oral tobramycin in ulcerative colitis: effect on maintenance of remission
LOBO, A. J., BURKE, D. A., SOBALA, G. M., & AXON, A. T. R. (1993) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1993.tb00084.x · Cited by 74
Changing faecal population of escherichia coli in hospital medical patients
Cooke, E. M., Ewins, S. P., & Shooter, R. A. (1969) · BMJ · doi:10.1136/bmj.4.5683.593 · Cited by 70
Prantera, C., Berto, E., Scribano, M. L., & Falasco, G. (1998) · PubMed · Cited by 70
Nutrition and Inflammatory Bowel Disease: An Update
Brummer, R. J., Stockbrügger, R. W., & Brummer, R.-J. M. (1999) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655299750025615 · Cited by 70
Antibodies to Mycobacterium paratuberculosis-specific protein antigens in Crohn's disease
Elsaghier, A. M., Prantera, C., Moreno, C., & Iványi, J. (1992) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1992.tb05874.x · Cited by 67
Walmsley, R. S., Anthony, A., Sim, R., Pounder, R. E., & Wakefield, A. J. (1998) · Journal of Clinical Pathology · doi:10.1136/jcp.51.9.657 · Cited by 66
Stainsby, K. J., Lowes, J. R., Allan, R. N., & Ibbotson, J. P. (1993) · Gut · doi:10.1136/gut.34.3.371 · Cited by 66
Alterations in the mucosal immune system in ulcerative colitis and crohn's disease
MacDermott, R. P. (1994) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30096-7 · Cited by 65
Mycobacterium paratuberculosis and Crohn's disease.
TANAKA, K., Wilks, M., Coates, P. J., Farthing, M. J. G., Walker‐Smith, J. A., & Tabaqchali, S. (1991) · Gut · doi:10.1136/gut.32.1.43 · Cited by 64
Jones, P. B., Fine, P., & Piracha, S. (1997) · The Lancet · doi:10.1016/s0140-6736(05)61184-1 · Cited by 59
Postoperative recurrence of Crohn's disease: The enemy is within the fecal stream
Sartor, R. B. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70492-5 · Cited by 56
Morgan, K. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92280-x · Cited by 56
Seasonal Variation in Exacerbations of Ulcerative Colitis
Tysk, C., & Järnerot, G. (1993) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529309096052 · Cited by 56
Gionchetti, P., Rizzello, F., Venturi, A., Matteuzzi, D., Rossi, M., Peruzzo, S., Poggioli, G., Bazzocchi, G., & Campieri, M. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)84011-0 · Cited by 51
ANTIBODIES AGAINST CHLAMYDIA OF LYMPHOGRANULOMA-VENEREUM TYPE IN CROHN'S DISEASE
Schuller, J. L., Veeken, I. V. D., Ulsen, J., MICHEL, M. F., & Stolz, E. (1979) · The Lancet · doi:10.1016/s0140-6736(79)90457-4 · Cited by 50
Hudson, M. J., Hill, M. J., Elliott, P. R., Berghouse, L. M., Burnham, W. R., & Lennard-Jones, J. E. (1984) · Journal of Medical Microbiology · doi:10.1099/00222615-18-3-335 · Cited by 49
Diet and the human intestinal bacterial flora.
Hill, M. J. (1981) · PubMed · Cited by 48
Gitnick, G., Rosen, V. J., Arthur, M. H., & Hertweck, S. A. (1979) · Digestive Diseases and Sciences · doi:10.1007/bf01333705 · Cited by 47
Factors inducing relapse in inflammatory bowel disease.
Mee, A. S., & Jewell, D. P. (1978) · BMJ · doi:10.1136/bmj.2.6140.801-a · Cited by 46
Rolfe, R. D. (1997) · Springer eBooks · doi:10.1007/978-1-4757-0322-1_13 · Cited by 46
Listeria isolations from feces of patients with diarrhea and from healthy food handlers
Müller, H. E. (1990) · Infection · doi:10.1007/bf01641423 · Cited by 45
Smoking: Good or bad for inflammatory bowel disease?
Rhodes, J., & Thomas, G. A. O. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90719-6 · Cited by 44
Iizuka, M., Chiba, M., Yukawa, M., Nakagomi, T., Fukushima, T., Watanabe, S., & Nakagomi, O. (2000) · Gut · doi:10.1136/gut.46.2.163 · Cited by 44
Miyamoto, H., Tanaka, T. N., Kitamoto, N., Fukuda, Y., & Shimoyama, T. (1995) · Journal of Gastroenterology · doi:10.1007/bf01211371 · Cited by 42
The Effect of Metronidazole and Sulfasalazine on the Fecal Flora in Patients with Crohn's Disease
Krook, A. L., Danielsson, D. G., Kjellander, J., & Järnerot, G. (1981) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528109181954 · Cited by 39
Exacerbation of ulcerative colitis
Hermens, D. J., & Miner, P. B. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90487-6 · Cited by 37
Long, A. A., & Komminoth, P. (2003) · Humana Press eBooks · doi:10.1385/0-89603-395-3:141 · Cited by 37
Poor sulphoxidation ability in patients with food sensitivity.
Scadding, G. K., Ayesh, R., Brostoff, J., Mitchell, S. C., Waring, R. H., & Smith, R. L. (1988) · BMJ · doi:10.1136/bmj.297.6641.105 · Cited by 36
Hirv, K., Seyfarth, M., Uibo, R., & K, K. (1999) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655299750025147 · Cited by 36
Serum agglutinins toEubacteriumandPeptostreptococcusspecies in Crohn's and other diseases
Wensinck, F., & van de Merwe, J. P. (1981) · Journal of Hygiene · doi:10.1017/s0022172400069199 · Cited by 35
LOW FREQUENCY OF CHLAMYDIAL ANTIBODIES IN PATIENTS WITH CROHN'S DISEASE AND ULCERATIVE COLITIS
TAYLOR‐ROBINSON, D., Thomas, B. J., O’Morain, C. A., & Levi, A. J. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91843-9 · Cited by 34
Genetics of Inflammatory Bowel Disease: A Reappraisal
Orchard, Satsangi, van Heel, D. A., & Jewell (2000) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.2000.00656.x · Cited by 34
Gall, L. S. (1970) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/23.11.1457 · Cited by 33
Are Antibiotics Useful in the Management of Nontoxic Severe Ulcerative Colitis?
Peppercorn, M. A. (1993) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199307000-00005 · Cited by 32
Is measles infection associated with Crohn's disease?
Metcalf, J. (1998) · BMJ · doi:10.1136/bmj.316.7126.166 · Cited by 29
Isotypic Analysis of Antibody Response to a Food Antigen in Inflammatory Bowel Disease
Paganelli, R., Pallone, F., Montano, S., Moli, S. L., Matricardi, P. M., Fais, S., Paoluzi, P., D'Amelio, R., & Aiuti, F. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000233867 · Cited by 27
Darroch, C. J., Barnes, R. M. R., & Dawson, J. (1999) · Journal of Clinical Pathology · doi:10.1136/jcp.52.1.47 · Cited by 27
Chlamydiae and inflammatory bowel disease.
Elliott, P. R., Forsey, T., Darougar, S., Treharne, J. D., & Lennard‐Jones, J. E. (1981) · Gut · doi:10.1136/gut.22.1.25 · Cited by 24
Antibiotics in inflammatory bowel disease: new choices for an old disease.
Spirt, M. J. (1994) · PubMed · Cited by 24
van de Merwe, J. P., Schmitz, P. I. M., & Wensinck, F. (1981) · Journal of Hygiene · doi:10.1017/s0022172400069205 · Cited by 19
Balzola, F. A., Castellino, F., Colombatto, P., Manzini, P. M., Astegiano, M., Verme, G., Brunetto, M. R., Pera, A., & Bonino, F. (1997) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199707000-00003 · Cited by 16
IgM-specific measles-virus antibody in families with a high frequency of Crohn's disease
Touze, I., Dubucquoi, S., Cortot, A., Kruiningen, H. V., & Colombel, J. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91587-7 · Cited by 14
Spondyloarthropathy and Idiopathic Inflammatory Bowel Diseases
Meuwissen, S. G. M., Crusius, J. B. A., Peña, A. S., Dekker-Saeys, A. J., & Dijkmans, B. A. C. (1997) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780030107 · Cited by 12
Self-citationInfectious agents and Crohn's disease
Bulois, P., Desreumaux, P., Neut, C., Darfeuille–Michaud, A., Cortot, A., & Colombel, J. (1999) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.1999.tb00415.x · Cited by 10
Viruses and Inflammatory Bowel Disease: Is There Evidence for a Causal Association?
Bernstein, C. N., & Blanchard, J. (2000) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200002000-00005 · Cited by 10
Stein, R. B., & Hanauer, S. B. (1998) · The Journal of critical illness · Cited by 6
Spondyloarthropathy and Idiopathic Inflammatory Bowel Diseases
Meuwissen, S. G. M., Crusius, B. J. A., Peña, S. A., et al. (1997) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199703000-00006 · Cited by 6
Self-citationBouma, G., Poen, A. C., García-González, M. A., Schreuder, G., Felt-Bersma, R. J. F., Meuwissen, S. G. M., & Peña, A. S. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)83823-7 · Cited by 4
Self-citation
Research works printed but not linked: 19
- Gorbach SL Levitan R. Intestinal flora in health and gastrointestinal diseases. In: Glass GBJ editor. Progress in gastroenterology vol. 2. New York: Grune and Stratton; 1970. p. 252–75.
- Drasar BS Hill MJ. Human intestinal microflora. New York: Academic Press; 1974.
- Chadwick VS Anderson RP. Microorganisms and their products in inflammatory bowel disease. In: McDermott RP Stimpson WF editors. Inflammatory bowel disease. New York: Elsevier; 1992. p. 241–58.
- Neutra MR Giannasca PJ et al. M cells and microbial pathogens. In: Blaser MJ Smith PD Ravdin JI Greenberg JB Guerrant RL editors. Infections of the gastrointestinal tract. New York: Raven Press; 1995. p. 163–78.
- Sartor RB. Microbial factors in the pathogenesis of Crohn’s disease ulcerative colitis and experimental intestinal inflammation. In: Kirsner JB editor. Inflammatory bowel disease 5th ed. Philadelphia: W. B. Saunders; 2000. p. 153–78.
- Bouma G Poen AC Garcia-Gonzalez MA Schreuder GMT Felt-Bersma RJF Meuwissen SGM et al. HLA-DR3B1*03 but not the TNFa-308 promoter gene polymorphism protection against fistulising Crohn’s disease. Immunogenetics 1998;47: 451–5. · doi:10.1007/s002510050382
- Stokkers PCF, Reitsma PH, Tytgat GNJ, van Deventer SJH. HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis. Gut 1999;45:395–401.
- Thomas GA, Rhodes J, Green JT. Inflammatory bowel disease and smoking—a review. Am J Gastroenterol 1998;43:144–9.
- Russel MGWM, Dorant E, Brummer RJM, van de Kruys MA, Muris WJ, Bergers JM, et al. Appendectomy and the risk of developing ulcerative colitis or Crohn’s disease: result of a large case-control study. Gastroenterology 1997;113:377–82.
- Miner PB. Factors influencing the relapse of patients with inflammatory bowel disease. Am J Gastroenterol 1997;92:1S–4S.
- Chiodini RJ, van Kruiningen HJ, Thayer Jr WR, Merkal RS, Coutu JA. Possible role of mycobacteria in inflammatory bowel disease. An unclassifi ed mycobacterium species isolated from patients with Crohn’s disease. Dig Dis Sci 1984;29: 1073–9.
- Stein R, Hanauer SB. Life-threatening complications of IBD: How to handle fulminant colitis and toxic megacolon. J Crit Illness 1998;13:518–21.
- Becker JM, Onderdonk AB. Bacterial dysbiosis in the pathogenesis of ileal pouchitis. Gastroenterology 1994;106:A650.
- Greenbloom SL, Steinhart AH, Greenberg GR. Combination ciprofloxacin and metronidazole for active Crohn’s disease. Can J Gastroenterol 1998;12:53–6.
- 10.1111/j.1572-0241.1999.935_q.x · doi:10.1111/j.1572-0241.1999.935_q.x · Paper page
- Solomon MJ, McLeod RS, O’Connor BI, Steinhart AH, Greenberg GR, Cohen Z. Combination ciprofloxacin and metronidazole in severe perianal Crohn’s disease. Can J Gastroenterol 1993;7:571–3.
- Schaafsma G. State of the art concerning probiotic strains in milk products. IDF Nutr Newsl 1996;5:241–5.
- 10.1111/j.1574-695x.1999.tb01381.x · doi:10.1111/j.1574-695x.1999.tb01381.x · Paper page
- Gorbach SL, Chang T, Goldin B. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 1987;ii:1519.
Cited by
Machiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., Ballet, V., Claes, K., Van Immerseel, F., Verbeke, K., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304833 · Cited by 1,904
Sartor, R. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.024 · Cited by 1,052
Wehkamp, J., Harder, J., Weichenthal, M., Schwab, M., Schäffeler, E., Schlee, M., Herrlinger, K. R., Stallmach, A., Noack, F., Fritz, P., et al. (2004) · Gut · doi:10.1136/gut.2003.032805 · Cited by 823
Dysbiosis in inflammatory bowel disease
Tamboli, C. P., Neut, C., Desreumaux, P., & Colombel, J. F. (2004) · Gut · doi:10.1136/gut.53.1.1 · Cited by 743
Rapid and Noninvasive Metabonomic Characterization of Inflammatory Bowel Disease
Marchesi, J. R., Holmes, E., Khan, F., Kochhar, S., Scanlan, P., Shanahan, F., Wilson, I. D., & Wang, Y. (2007) · Journal of Proteome Research · doi:10.1021/pr060470d · Cited by 631
Metadata
- Authors
- Linskens, R. K., Huijsdens, X. W., Savelkoul, P. H. M., Vandenbroucke-Grauls, C. M. J. E., & Meuwissen, S. G. M.
- Affiliations
- Vrije Universiteit Amsterdam (NL)
- Depts. of Gastroenterology and Medical Microbiology, Academic Hospital Vrije Universiteit Amsterdam, The Netherlands
- ORCID
- Savelkoul, P. H. M.
- Venue
- Scandinavian Journal of Gastroenterology
- Publisher
- Informa UK Limited
- Published
- 2001-01
- Volume
- 36
- Issue
- 234
- Pages
- 29-40
- ISSN
- 0036-5521 (ISSN-L)
- 1502-7708
- OpenAlex
- W2119336597
- Cited by
- 233
- References
- 152
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 5 · 2023: 2 · 2022: 4 · 2021: 5 · 2020: 3 · 2019: 5 · 2018: 4 · 2017: 8 · 2016: 10 · 2015: 8 · 2014: 6 · 2013: 16 · 2012: 11
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Scandinavian Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- inflammatory bowel disease, gut microbiota, bacterial flora, Crohn's disease, ulcerative colitis, pathogenesis, mucosal permeability, epithelial barrier function, mucosal immunity, Bacteroides, Bifidobacterium, Peptostreptococcus, facultative anaerobes, probiotics, antibiotics, elemental diet, total parenteral nutrition, germ-free animals
- MeSH terms
- Anti-Bacterial Agents, Colon, Humans, Intestinal Mucosa, Inflammatory Bowel Diseases, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.